Nanjing Vazyme Biotech Co Ltd
SSE:688105
Nanjing Vazyme Biotech Co Ltd
Total Current Liabilities
Nanjing Vazyme Biotech Co Ltd
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nanjing Vazyme Biotech Co Ltd
SSE:688105
|
Total Current Liabilities
¥1.5B
|
CAGR 3-Years
85%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Total Current Liabilities
¥12.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Total Current Liabilities
¥4.5B
|
CAGR 3-Years
44%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Total Current Liabilities
¥2.7B
|
CAGR 3-Years
48%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Total Current Liabilities
¥18.1B
|
CAGR 3-Years
33%
|
CAGR 5-Years
38%
|
CAGR 10-Years
68%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Total Current Liabilities
¥224.2m
|
CAGR 3-Years
49%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
See Also
What is Nanjing Vazyme Biotech Co Ltd's Total Current Liabilities?
Total Current Liabilities
1.5B
CNY
Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Total Current Liabilities amounts to 1.5B CNY.
What is Nanjing Vazyme Biotech Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
80%
Over the last year, the Total Current Liabilities growth was 32%. The average annual Total Current Liabilities growth rates for Nanjing Vazyme Biotech Co Ltd have been 85% over the past three years , 80% over the past five years .